Jobs / United States / Stoke Therapeutics INC

Stoke Therapeutics INC

Senior Director, Investor Relations

Bedford, Massachusetts, United States Posted 10 days ago

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Mar 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Mar 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ Position Purpose: The Sr. Director, Investor Relations will be responsible for leading the development and execution of Stoke’s strategic planning and engagement with the investment community to support the company’s goal of ensuring an accurate understanding of the company’s vision, strategy and its fair valuation. As the primary point of contact for all Stoke investor relations, s/he will establish and maintain credibility and trust with the investment community, including current shareholders, prospective shareholders and sell-side financial analysts. This position will report to the Chief of Corporate Affairs and Strategic Partnerships and will work closely with members of the executive team, providing guidance on all investor interactions. Key Responsibilities: • Lead investor relations efforts on behalf of Stoke, including the development and implementation of a strategic plan that helps ensure an accurate understanding of the company story (vision, strategy, pipeline, competitive position) and a fair valuation. • Cultivate and maintain strong relationships with investors (current and potential future) and sell-side research analysts. • Effectively anticipate investor needs by maintaining a current understanding of the industry and competitive landscape as well as a deep understanding of Stoke’s business and progress. • Serve as primary point of contact for all investor inquiries, providing timely, consistent, compliant and accurate responses. • Monitor and assess market and sector dynamics as well as all investment research (including models and estimates) on Stoke and its industry peers. • Provide data and metrics-driven insights into the market and competitive landscape, using the information to counsel senior management and guide investor communications and activities. • Provide internal and external audiences with an accurate and timely view of the company’s performance and perception among the investment community. Provide feedback to management and advise the organization on ways to engage and continuously improve. • Continuously evaluate Stoke’s performance with investors and use data, including keen observation and critical thinking skills, to guide Stoke’s ongoing investor-focused activities. • Work to establish the optimal mix of shareholders for Stoke at each stage of its evolution through strategic and thoughtful targeting initiatives. • Partner closely with Finance, Legal and other departments to ensure accurate and appropriate information for financial reporting, including as part of quarterly communications and regular SEC filings. • Partner closely with business partners and collaborators on investor-facing content and disclosures. • Work collaboratively across the organization to stay current on company progress to guide investor-fo

Apply on employer site ↗